Welcome to our dedicated page for Skyward Specialty Insurance Group SEC filings (Ticker: SKWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a specialty commercial property and casualty insurer. As a Nasdaq Global Select Market registrant, Skyward Specialty files current and periodic reports with the U.S. Securities and Exchange Commission that describe its financial condition, capital structure, governance, and material events.
Investors can review Form 8-K filings for information on material definitive agreements, credit facilities, acquisitions, and governance developments. For example, recent 8-K filings describe a new unsecured revolving credit agreement with specified covenants and an accordion feature, the termination of a prior credit agreement, and share purchase agreements related to the acquisition of Apollo Group Holdings Limited. Other 8-Ks report quarterly results and board changes, such as the election of a new independent director and planned Audit Committee leadership transitions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via this page when filed) provide more detailed information on Skyward Specialty’s underwriting divisions, specialty P&C operations, risk factors, and financial statements. These filings also discuss topics such as reinsurance arrangements, reserves, investment portfolios, and non-GAAP financial measures used by management.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping users quickly identify items such as changes in credit arrangements, acquisition terms, or underwriting performance metrics. The filings page is also a resource for tracking any future Forms 3, 4, or 5 related to insider transactions, as well as proxy statements that address board composition and executive-related matters, when such documents are filed with the SEC.
Skyward Specialty Insurance Group, Inc. agreed to acquire Apollo Group Holdings Limited for $556,000,000, buying approximately 87% of Apollo now and aiming to acquire 100% at closing. About 33% of the purchase price will be paid with common stock: the Company will issue 3,679,332 shares as consideration to certain sellers and pay the remainder in cash.
The cash portion is expected to be funded in part by a new $300 million term loan underwritten by Barclays. Completion is expected in the first quarter of 2026 but is subject to signing additional short-form agreements with minority sellers and receipt of regulatory approvals, including from the UK Prudential Regulation Authority, Lloyd's and the Bermuda Monetary Authority. If closing conditions are unmet by June 2, 2026, the majority SPAs terminate automatically.
Skyward Specialty Insurance Group reported material insurance reserves and a control weakness while maintaining regulatory capital and recent financing activity. The company held $1.8 billion of reserves for unpaid losses and loss adjustment expenses at December 31, 2024, with a significant portion as IBNR estimated by actuarial methods and subject to estimation uncertainty. The auditor communicated a valuation critical audit matter on reserve estimates and expressed an adverse opinion on internal control over financial reporting. Reinsurance recoverables included concentrations with Everest Reinsurance Co. (18.0%) and eMaxx Captives (16.8%) and reinsurance collateral totaled $337.0 million. Financing actions included a $57.0 million FHLB term loan secured by pledged securities and earlier IPO and follow-on offerings that generated approximately $62.0 million and $62.5 million net proceeds respectively. Statutory measures showed net income of $108.2 million and statutory capital and surplus of $710.6 million for 2024.